Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4032450)

Published in BMC Cancer on May 19, 2014

Authors

Reza Ghiasvand, Hans-Olov Adami, Iraj Harirchi, Rahim Akrami, Kazem Zendehdel1

Author Affiliations

1: Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran. kzendeh@tums.ac.ir.

Articles cited by this

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Permutation tests for joinpoint regression with applications to cancer rates. Stat Med (2000) 24.62

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28

Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60

The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer (2007) 10.60

Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst (2007) 6.08

Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol (2005) 5.63

Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52

Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev (2004) 5.32

Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ (2004) 4.94

Use of statistics to assess the global burden of breast cancer. Breast J (2006) 2.56

Breast cancer in Iran: an epidemiological review. Breast J (2007) 2.55

Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev (1995) 2.50

Early onset of breast cancer in a group of British black women. Br J Cancer (2008) 2.47

Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev (2005) 2.37

Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg (2006) 2.33

Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00

Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol (1992) 1.86

Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev (2004) 1.72

Breast cancer in Iran: a review of 903 case records. Public Health (2000) 1.63

Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst (2006) 1.49

Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer (2005) 1.45

Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev (2007) 1.30

Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer (2002) 1.27

Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas (2010) 1.26

Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries. Cancer (2001) 1.23

Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol (1999) 1.19

Reasons for breast cancer heterogeneity. J Biol (2008) 1.17

Relation between obesity and breast cancer in young women. Am J Epidemiol (1999) 1.14

Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res (2010) 1.08

Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer (1995) 1.02

Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst (2006) 1.01

Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example. J Steroid Biochem Mol Biol (2010) 0.94

Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer (1998) 0.86

Postmenopausal breast cancer in Iran; risk factors and their population attributable fractions. BMC Cancer (2012) 0.84

Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme. Breast Cancer Res Treat (2008) 0.83

Breast cancer and age in Black and White women in South East England. Int J Cancer (2011) 0.80

Preventable breast cancer is postmenopausal. Breast Cancer Res Treat (2010) 0.77

Articles by these authors

(truncated to the top 100)

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2005) 16.35

Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med (2002) 10.64

Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06

Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst (2008) 8.62

Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78

Natural history of early, localized prostate cancer. JAMA (2004) 7.44

The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85

Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74

Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ (2012) 4.05

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84

Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ (2004) 3.67

Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55

Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol (2011) 3.45

The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44

A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst (2003) 3.29

Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst (2005) 3.19

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84

Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet (2002) 2.72

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62

Average energy intake among pregnant women carrying a boy compared with a girl. BMJ (2003) 2.55

Breast cancer in Iran: an epidemiological review. Breast J (2007) 2.55

Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49

Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol (2014) 2.35

Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol (2012) 2.28

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst (2006) 2.23

The socioeconomic gradient in the incidence of stroke: a prospective study in middle-aged women in Sweden. Stroke (2006) 2.23

Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19

Breast self-examination: knowledge, attitudes, and practices among female health care workers in Tehran, Iran. Breast J (2002) 2.18

Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18

Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08

Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99

A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.97

Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med (2008) 1.93

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res (2004) 1.91

Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88

Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2007) 1.87

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev (2004) 1.82

Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79

Multiple myeloma: a review of the epidemiologic literature. Int J Cancer (2007) 1.78

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77

Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst (2006) 1.68

Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol (2007) 1.68

Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev (2005) 1.66

Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev (2011) 1.61

Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer (2012) 1.61

Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol (2003) 1.59

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58

Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev (2010) 1.56

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst (2005) 1.55

Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev (2002) 1.54

Optimizing the design of web-based questionnaires--experience from a population-based study among 50,000 women. Eur J Epidemiol (2007) 1.51

Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res (2009) 1.51

Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst (2012) 1.50

Consumption of fish products across the lifespan and prostate cancer risk. PLoS One (2013) 1.46

Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study. BMC Cancer (2008) 1.45

Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer (2005) 1.45

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res (2007) 1.45

mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol (2011) 1.40

Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr (2006) 1.40

A global assessment of the oesophageal adenocarcinoma epidemic. Gut (2012) 1.40

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.39

LifeGene--a large prospective population-based study of global relevance. Eur J Epidemiol (2010) 1.38

[Unexpected findings--sunlight can protect against cancer]. Lakartidningen (2005) 1.38

Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst (2007) 1.37

Screening for prostate cancer remains controversial. BMJ (2009) 1.34

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev (2005) 1.33

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate (2009) 1.33

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res (2004) 1.32

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell (2010) 1.29

Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev (2005) 1.29

Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst (2005) 1.29

Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer (2008) 1.28

Hepatitis C infection and risk of malignant lymphoma. Int J Cancer (2008) 1.27

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A (2010) 1.27

Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med (2009) 1.26

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst (2004) 1.26

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiol Biomarkers Prev (2008) 1.26

Ethnic differences in survival after breast cancer in South East Asia. PLoS One (2012) 1.26

Established prostate cancer susceptibility variants are not associated with disease outcome. Cancer Epidemiol Biomarkers Prev (2009) 1.24

A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.23

Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol (2011) 1.23

Body mass index and mortality in a prospectively studied cohort of Scandinavian women: the women's lifestyle and health cohort study. Eur J Epidemiol (2005) 1.22

Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States). Cancer Causes Control (2003) 1.22

Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol (2005) 1.22

Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res (2008) 1.22

The relationship between serum levels of vitamin D and migraine. J Res Med Sci (2013) 1.20

Is breast cancer prognosis inherited? Breast Cancer Res (2007) 1.20